Skip to main content
. 2009 Nov 20;19(3):526–534. doi: 10.1093/hmg/ddp519

Table 2.

Primary meta-analysis results

Gene Polymorphism rs number Contrast OR Studiesa Allelesb I2
ACE Indel del→ ins 1.12 (0.92–1.38) 6 1746 0.00
ADRB2 +46 AG rs1042713 A to G 1.11 (0.75–1.65) 5 2340 0.77
ADRB2 +79 CG rs1042714 C to G 0.89 (0.51–1.41) 5 2362 0.82
EPHX1 His139Arg rs2234922 A to G 1.06 (0.91–1.23) 15 9380 0.39
EPHX1 Tyr113His rs1051740 C to T 1.11 (0.95–1.30) 15 9374 0.65
GSTP1 Ile105Val rs1695 A to G 1.09 (0.80–1.48) 10 6228 0.83
IL13 +2044 GA A to G 1.00 (0.76–1.31) 4 1276 0.00
IL13 −1055 CT C to T 0.73 (0.35–1.56) 3 1072 0.83
IL1B −31 TC C to T 0.95 (0.62–1.46) 4 1066 0.54
IL1B −511 CT C to T 1.40 (0.94–2.07) 5 884 0.71
IL4 −33 CT rs2070874 C to T 1.05 (0.79–1.38) 4 1192 0.00
IL6 −174 GC C to G 0.98 (0.77–1.25) 5 1354 0.00
LTA +252 AG A to G 1.00 (0.78–1.28) 4 1596 0.00
MMP9 −1562 CT C to T 0.69 (0.44–1.09) 4 1700 0.42
SERPINA3 Ala9Thr A to G 0.80 (0.62–1.03) 5 2676 0.45
SOD3 Arg213Gly rs1799895 C to G 1.97 (1.24–3.13) 3 18392 0.00
TGFB1 −509 CT rs1800469 C to T 1.05 (0.70–1.58) 4 5030 0.85
TGFB1 +29 TC rs1800470 C to T 0.73 (0.64–0.83) 5 5256 0.00
TIMP2 +853 GA rs2277698 A to G 0.59 (0.23–1.48) 3 2102 0.89
TNF +489 GA rs1800610 A to G 1.26 (0.96–1.66) 6 2848 0.00
TNF −1031 TC rs1799964 C to T 0.89 (0.67–1.17) 3 1670 0.00
TNF −238 GA rs361525 A to G 0.82 (0.57–1.19) 5 3672 0.04
TNF −308 GA rs1800629 A to G 1.19 (1.01–1.40) 27 11812 0.34
TNF −857 CT rs1799724 C to T 1.04 (0.77–1.40) 3 1606 0.00
TNF −863 CA rs1800630 A to C 0.91 (0.67–1.24) 3 1646 0.00
GSTM1 Null null → wt 1.45 (1.09–1.92) 8 2523 0.62
GSTT1 Null null → wt 0.92 (0.73–1.15) 5 1408 0.00

Meta-analyses performed for variants studied in three or more independent study populations. Random-effects meta-analysis performed using an allele-based model.

aNumber of case–control comparisons in which a variant has been tested for association with COPD.

bNumber of alleles included in meta-analysis (i.e. # of individuals x 2).